FMC Corporation Securities Lawsuit Investigation

Shamis & Gentile P.A., a law firm that advocates for investors who are victims of securities fraud, is investigating potential claims against FMC Corporation (FMC).

If you have held FMC Corporation since at least November 2023, you may be able to seek corporate reforms, the return of funds back to the Company, and a court approved incentive award for you, all at absolutely no cost.

About FMC

FMC Corporation is an agricultural sciences company incorporated in Delaware, with its principal executive offices in Philadelphia, Pennsylvania.

The company’s core business includes the development and sale of crop protection products such as insecticides, herbicides, fungicides, and a plant health biologicals platform.

What's Being Investigated

The current investigation centers on potential breaches of fiduciary duty by FMC’s board of directors, following a class action complaint filed on February 13, 2025. The complaint alleges that FMC and certain executives made materially false and/or misleading statements and failed to disclose adverse facts about the company’s business, operations, and prospects.

Allegations asserted in the class action complaint:

• FMC misrepresented the progress of its channel management initiatives and overstated how effectively it was managing inventory levels in its distribution channels
• The company failed to disclose a strategic decision to avoid price competition, choosing instead to walk away from certain sales opportunities rather than compete on price
• FMC concealed inflated inventory levels in distribution channels across key regions including Latin America (notably Brazil), Asia (including India), Canada, and Eastern Europe
• The company made positive statements about its business and outlook that allegedly were misleading or lacked a reasonable basis given the undisclosed problems

On February 4, 2025, FMC announced results that missed guidance, revealing elevated channel inventories across multiple regions and disclosed it had walked away from sales due to pricing pressure. On this news, FMC's stock declined approximately 33.5%, closing at $35.92 per share on February 5, 2025; resulting in significant harm to the company and investors.

Key Timeline

• November 16, 2023: FMC held its Investor Day, presenting a new strategic growth plan and preliminary 2024 outlook that set expectations for channel management progress and growth. Investors allege these statements misrepresented the true state of the company's channel management initiatives.
• May 6, 2024: FMC reported Q1 2024 results, stating revenue was down 32% but maintaining its full-year outlook. Investors allege the company concealed that it was walking away from sales opportunities due to pricing pressure and that inventory was building up in key markets.
• July 31, 2024: FMC announced Q2 2024 results with 2% revenue growth and updated (lowered) its full-year outlook. Investors allege management knew of elevated inventory levels in Latin America, Asia, Canada, and Eastern Europe but failed to disclose this material information.
• February 4, 2025: FMC announced its Q4/FY2024 results, with management noting that customers in several countries were holding significantly less inventory, which affected results. The company issued a muted 2025 outlook.
• February 5, 2025: FMC’s stock declined by 33.5% following the earnings release and outlook, which investors argue was linked to the alleged undisclosed issues.

Why Investors May Be Concerned

Stockholders and their counsel contend that FMC’s board and officers may have failed to provide accurate and complete information about key risks and business practices.

Theories raised in the complaint and by analysts include:

• Alleged misleading statements or omissions regarding the progress of channel management initiatives and inventory levels;
• Potential failure of the board to oversee mission-critical risks, such as inventory management and pricing strategies, which are repeatedly cited as key risks in the company’s filings.
• Questions about whether the board and audit committee had adequate controls and reporting systems to detect and address these risks;
• Concerns that officers may have directed or approved public statements that lacked a reasonable basis, potentially exposing the company to liability.

Your Rights and Next Steps

This is an active investigation into whether FMC Corporation’s board of directors or senior officers may have breached their fiduciary duties or failed to provide complete and accurate disclosures. If you have owned FMC shares since at least November 2023 and continue to hold shares, you may have certain rights.

Potential Next Steps:

• Request company records under Delaware law to investigate potential misconduct or governance failures.
• Submit a written demand to the board to address the alleged issues before any lawsuit is filed.
• Participate in a shareholder action, which is brought on behalf of the company to recover losses or implement governance reforms.
• Consult with legal counsel to understand your rights, deadlines, and ownership requirements under Delaware law.

It is important to act promptly, as there may be deadlines for submitting a board demand or joining any related action.

How Shareholders Can Take Action Today

Securities investigations are time-sensitive. If you have held FMC Corporation (FMC) shares since at least November 2023, you may be eligible to seek corporate governance reforms, the recovery of funds on behalf of the Company, and potentially a court-approved incentive award, all at no cost to you.

Please complete the form below to join the FMC Corporation investigation.